GRBK
Green Brick Partners, Inc.
GRBK has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over GRBK overall, supported by stronger fundamentals and stronger modeled upside.
GRBK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
GRBK's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GRBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $38.15 | -37% |
| Fair | 8.9x | $55.06 | -9.6% |
| Current | 9.8x | $60.92 | — |
| Expensive | 10x | $64.66 | +6.1% |
| Forward | 11x | $60.92 | — |
Historical ranges are pointers, not guarantees.
GRBK's PE is in its expensive range at 9.8x. Analysts expect earnings to fall, which would put today's price at 11x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GRBK Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect GRBK's earnings and profitability to decline, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GRBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.30 | -15% |
| Q3 2026 | $6.22 | -18% |
| Q2 2026 | $6.64 | -15% |
| Q1 2026 | $6.79 | -18% |
| Q4 2025 | $7.07 | -16% |
| Q3 2025 | $7.62 | -1% |
| Q2 2025 | $7.83 | +7.6% |
| Q1 2025 | $8.30 | +26% |
| Q4 2024 | $8.45 | +38% |
GRBK has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GRBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $448.2M | -10% |
| Q2 2026 | $493.8M | -10% |
| Q1 2026 | $465.5M | -6.5% |
| Q4 2025 | $536.8M | -5.4% |
| Q3 2025 | $499.1M | -4.7% |
| Q2 2025 | $549.1M | -2% |
| Q1 2025 | $497.6M | +11% |
| Q4 2024 | $567.3M | +26% |
GRBK's revenue has slid since its 2024 peak: $448M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | -4 points |
| Q2 2026 | 20% | -0.3 points |
| Q1 2026 | 18% | -3.2 points |
| Q4 2025 | 21% | -3.3 points |
| Q3 2025 | 21% | -1.3 points |
| Q2 2025 | 20% | -4.4 points |
| Q1 2025 | 21% | -4.5 points |
| Q4 2024 | 24% | +1.7 points |
GRBK has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GRBK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GRBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$53.7M | -$41.7M |
| Q2 2026 | -$9.8M | -113% |
| Q1 2026 | $55M | -19% |
| Q4 2025 | $78.4M | +180% |
| Q3 2025 | -$12M | -$4.7M |
| Q2 2025 | $74M | +9391% |
| Q1 2025 | $68M | +90612% |
| Q4 2024 | $28.1M | +$50.4M |
GRBK has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GRBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -75K shares |
| 1 year | -1% | -428K shares |
| 3 years | -5.7% | -2.6M shares |
| 5 years | -15% | -7.9M shares |
| Available history | -15% | -7.4M shares |
GRBK has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $17.9M |
| Q2 2026 | $9.4M |
| Q1 2026 | $7.3M |
| Q4 2025 | $23M |
| Q3 2025 | — |
| Q2 2025 | $43.8M |
| Q1 2025 | $16.9M |
| Q4 2024 | $393,000 |
GRBK spent $58M buying back its own shares over the past year, down 5.7% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
GRBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.4x | Very low |
GRBK's net debt is less than a year of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GRBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 19.7 | Oversold |
GRBK's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GRBK PE vs Consumer Cyclical Sector
| Metric | GRBK | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 18x | 46% below |
| PE % | 74 | 47 | 27 pts above |
GRBK is trading at 9.8x earnings, a 46% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GRBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.8 | 4.5% below |
| 20 week MA | $68.7 | 11% below |
| 50 week MA | $68.9 | 12% below |
| 100 week MA | $65.8 | 7.4% below |
| 200 week MA | $59.8 | 1.8% above |
GRBK has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GRBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.4 | $24.3 | +113% |
| 2021 | $24.3 | $29.9 | +23% |
| 2022 | $29.9 | $24.3 | -19% |
| 2023 | $24.3 | $51.9 | +114% |
| 2024 | $51.9 | $56.4 | +8.7% |
| 2025 | $56.4 | $63.8 | +13% |
| 2026 YTD | $63.8 | $60.9 | -4.5% |
GRBK has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.